Brokerages Anticipate DENTSPLY SIRONA Inc (XRAY) Will Post Quarterly Sales of $1.06 Billion

Analysts predict that DENTSPLY SIRONA Inc (NASDAQ:XRAY) will announce sales of $1.06 billion for the current quarter, according to Zacks. Nine analysts have made estimates for DENTSPLY SIRONA’s earnings, with the highest sales estimate coming in at $1.08 billion and the lowest estimate coming in at $1.03 billion. DENTSPLY SIRONA reported sales of $996.50 million in the same quarter last year, which would suggest a positive year-over-year growth rate of 6.4%. The firm is scheduled to report its next quarterly earnings report on Friday, February 23rd.

According to Zacks, analysts expect that DENTSPLY SIRONA will report full year sales of $1.06 billion for the current year, with estimates ranging from $3.93 billion to $3.99 billion. For the next year, analysts forecast that the business will report sales of $4.16 billion per share, with estimates ranging from $4.08 billion to $4.23 billion. Zacks’ sales averages are a mean average based on a survey of research firms that that provide coverage for DENTSPLY SIRONA.

XRAY has been the subject of a number of analyst reports. TheStreet raised DENTSPLY SIRONA from a “c” rating to a “b-” rating in a report on Friday, November 3rd. Stifel Nicolaus raised their price target on DENTSPLY SIRONA from $66.00 to $70.00 and gave the stock a “buy” rating in a report on Monday, November 6th. HC Wainwright reaffirmed a “buy” rating and issued a $68.00 price target on shares of DENTSPLY SIRONA in a report on Monday, November 6th. BidaskClub lowered DENTSPLY SIRONA from a “strong-buy” rating to a “buy” rating in a report on Saturday, December 2nd. Finally, Deutsche Bank initiated coverage on DENTSPLY SIRONA in a report on Friday, December 8th. They issued a “buy” rating and a $81.00 price target for the company. Three analysts have rated the stock with a sell rating, four have given a hold rating and eight have given a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus price target of $69.15.

In related news, Director Eric Brandt sold 6,409 shares of the stock in a transaction on Monday, January 8th. The stock was sold at an average price of $68.04, for a total value of $436,068.36. Following the sale, the director now owns 12,073 shares in the company, valued at $821,446.92. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Company insiders own 1.99% of the company’s stock.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Xact Kapitalforvaltning AB raised its position in DENTSPLY SIRONA by 11.7% during the fourth quarter. Xact Kapitalforvaltning AB now owns 35,470 shares of the medical instruments supplier’s stock valued at $2,335,000 after purchasing an additional 3,729 shares in the last quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp raised its position in DENTSPLY SIRONA by 15.5% during the fourth quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 125,522 shares of the medical instruments supplier’s stock valued at $8,263,000 after purchasing an additional 16,810 shares in the last quarter. OLD Mutual Customised Solutions Proprietary Ltd. raised its position in DENTSPLY SIRONA by 57.4% during the fourth quarter. OLD Mutual Customised Solutions Proprietary Ltd. now owns 12,067 shares of the medical instruments supplier’s stock valued at $794,000 after purchasing an additional 4,400 shares in the last quarter. Sterling Capital Management LLC purchased a new stake in DENTSPLY SIRONA during the fourth quarter valued at about $1,927,000. Finally, MetLife Investment Advisors LLC purchased a new stake in DENTSPLY SIRONA during the fourth quarter valued at about $4,678,000. Institutional investors and hedge funds own 96.05% of the company’s stock.

DENTSPLY SIRONA (NASDAQ XRAY) traded down $0.09 during trading on Monday, hitting $58.06. The stock had a trading volume of 2,299,700 shares, compared to its average volume of 2,461,422. DENTSPLY SIRONA has a 52-week low of $52.53 and a 52-week high of $68.98. The company has a quick ratio of 1.59, a current ratio of 2.32 and a debt-to-equity ratio of 0.21. The company has a market capitalization of $13,230.00, a price-to-earnings ratio of -16.57, a P/E/G ratio of 2.15 and a beta of 1.17.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 13th. Investors of record on Thursday, March 29th will be given a $0.0875 dividend. The ex-dividend date of this dividend is Wednesday, March 28th. This represents a $0.35 dividend on an annualized basis and a dividend yield of 0.60%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -10.06%.

TRADEMARK VIOLATION WARNING: “Brokerages Anticipate DENTSPLY SIRONA Inc (XRAY) Will Post Quarterly Sales of $1.06 Billion” was posted by StockNewsTimes and is owned by of StockNewsTimes. If you are viewing this news story on another domain, it was stolen and republished in violation of US and international copyright laws. The correct version of this news story can be accessed at https://stocknewstimes.com/2018/02/22/brokerages-anticipate-dentsply-sirona-inc-xray-will-post-quarterly-sales-of-1-06-billion.html.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Get a free copy of the Zacks research report on DENTSPLY SIRONA (XRAY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply